Cardiogenic Shock Working Group Registry

Part of paid clinical trials in Weston, Florida.

Sponsor
Tufts Medical Center
Study ID
NCT04682483
Status
Recruiting

Conditions

  • Cardiogenic Shock

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Vasopressor — DRUG
    The vasopressors include phenylephrine, norepinephrine, epinephrine, dopamine and vasopressin.
  • Inotrope — DRUG
    Inotropes include dobutamine and milrinone.
  • Acute Mechanical Circulatory Support Devices — DEVICE
    Acute Mechanical Circulatory Support devices include ECMO (VV), ECMO (VA), Impella CP, Impella 2.5, Impella 5.0, Impella 5.5, Impella RP, IABP, Centrimag, Tandem Heart and ProTek Duo.

Study Details

The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.

Key Dates

Start date
Dec 4, 2017
Status verified
Jun 2025
Primary completion
Jan 1, 2026
Completion
Jun 1, 2026

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Cardiogenic Shock Patients
    Cardiogenic Shock patients eligible for this study are defined by at least one of the two categories below. 1. Patients have at least 2 of the following concurrently at any point during the index hospitalization: MAP \< 60mmHg or a \>30mmHg drop in MAP from baseline, SBP \< 90mmHg or a \>30mmHg drop in SBP from baseline, Pulse \> 100, Cardiac Index \< 2.2, Cardiac Power Output ≤ 0.6 or PAPI \< 1.0. 2. Patients require the use of at least 1 vasopressor, inotrope or acute mechanical circulatory support device to maintain values above the above targets.

Primary Outcome Measure

Rate of Mortality [ Time Frame: 30 days after discharge ]

Central Contacts

Locations (16)

FacilityCityStateZIPSite coordinators
Cleveland Clinic FloridaWestonFlorida33331
Jaime Hernandez-Montfort, MD MPH
Jaime Hernandez-Montfort, MD MPH (PRINCIPAL_INVESTIGATOR)
Northwestern MedicineChicagoIllinois60611
Esther Vorovich, MD
Esther Vorovich (PRINCIPAL_INVESTIGATOR)
University of ChicagoChicagoIllinois60612
Sandeep Nathan, MD
Sandeep Nathan, MD (PRINCIPAL_INVESTIGATOR)
Maine Medical CenterPortlandMaine04102
Andrew Schwartzman, MD
Andrew Schwartzman, MD (PRINCIPAL_INVESTIGATOR)
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Arthur R Garan
Arthur R Garan, MD (PRINCIPAL_INVESTIGATOR)
Tufts Medical CenterBostonMassachusetts02111
Navin K Kapur, MD
6176366140
Navin Kapur, MD (PRINCIPAL_INVESTIGATOR)
Hackensack Meridian HealthHackensackNew Jersey07601
Haroon Faraz, MD
Haroon Faraz, MD (PRINCIPAL_INVESTIGATOR)
Columbia University Irving Medical CenterNew YorkNew York10032
Justin Fried, MD
Justin Fried, MD (PRINCIPAL_INVESTIGATOR)
Providence St. Vincent Heart ClinicPortlandOregon97225
Jacob Abraham, MD
Jacob Abraham, MD (PRINCIPAL_INVESTIGATOR)
Allegheny General HospitalPittsburghPennsylvania15212
Manreet Kanwar, MD
Manreet Kanwar, MD (PRINCIPAL_INVESTIGATOR)
University Of Pittsburgh Medical CenterPittsburghPennsylvania15261
Gavin Hickey, MD
Gavin Hickey, MD (PRINCIPAL_INVESTIGATOR)
Baylor Scott & White Advanced Heart Failure ClinicDallasTexas75201
Detlef Wencker, MD
Detlef Wencker, MD (PRINCIPAL_INVESTIGATOR)
University of Texas Medical BranchGalvestonTexas77555
Wissam Khalife, MD
Wissam Khalife
Houston Methodist HospitalHoustonTexas77030
: Ju H Kim, MD
Ju H Kim, MD (PRINCIPAL_INVESTIGATOR)
Inova Health SystemFalls ChurchVirginia22042
Shashank Sinha, MD, MSc
Shashank Sinha, MD, MSc (PRINCIPAL_INVESTIGATOR)
University of Washington Medical CenterSeattleWashington98195-9472
Claudius Mahr, DO
Claudius Mahr, DO (PRINCIPAL_INVESTIGATOR)

Find similar trials in Weston, FL

Related Studies